The six-year product’s performance is linked to the top 10 companies in the FTSE 100 as at the 8 February 2012.
If on any annual measurement date during the product’s term at least eight out of the ten companies are equal to or greater than their respective opening levels then the plan will kick-out paying 15% gross of the money invested for each year the plan has been in force.
The ten companies involved are: AstraZeneca, BG Group, BHP Billiton, BP, British American Tobacco, GlaxoSmithKline, HSBC, Rio Tinto, Royal Dutch Shell A and Vodafone.
In the event that not growth payment is triggered on any of the annual measurement dates, the capital return at maturity will be based on the performance of the FTSE 100 index and could be eroded.
Investors would lose all of their money if the closing level of the index on the final day of the plan is more than 50% lower than its opening level. In this case the capital will be reduced by the same percentage that the final level of the index is below its opening level.
The minimum investment into the plan is £10,000 and the counterparty is BNP Paribas.
